Showing results (1831-1840 of 6,739) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|February 15, 2018
Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significanceJinyun Li, Dong Ye, Lei Wang, et al.Oncotargets and Therapy|February 15, 2018
Association between IL-17A G197A polymorphism and gastric cancer risk: an updated meta-analysis based on 6,624 cases and 7,631 controlsLixia Hu, Fanliang Kong, Yueyin PanOncotargets and Therapy|February 15, 2018
Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studiesXinming Han, Yan Han, Yongsheng Zheng, et al.Oncotargets and Therapy|November 16, 2017
Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemiaRui Huang, Xiwen Liao, Qiaochuan LiOncotargets and Therapy|October 19, 2017
TERT-CLPTM1 locus polymorphism (rs401681) is associated with the prognosis of hepatocellular carcinomaHye Won Lee, Won-Jin Park, Yu-Ran Heo, et al.Oncotargets and Therapy|October 19, 2017
ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapyFangbin Song, Jianbing Zhang, Shanbao Li, et al.Oncotargets and Therapy|January 31, 2018
miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cellsTe-Fu Tsai, Ji-Fan Lin, Kuang-Yu Chou, et al.Oncotargets and Therapy|January 31, 2018
A support vector machine and a random forest classifier indicates a 15-miRNA set related to osteosarcoma recurrenceYunfei He, Jun Ma, An Wang, et al.Oncotargets and Therapy|December 21, 2018
Afatinib reverses ceritinib resistance (CR) in ALK/ROS1-positive non-small-cell lung cancer cell (NSCLC) via suppression of NRG1 pathwayHui Chen, Qiang Zhang, Yu Zhang, et al.Oncotargets and Therapy|December 21, 2018
Erratum: MTBP promotes migration and invasion by regulation of ZEB2-mediated epithelial-mesenchymal transition in lung cancer cells [Corrigendum]Pageof 674